AIM ImmunoTech Inc. AIM 26.57
Health Care · NYSE · Data as of 2026-07-09
AIM ImmunoTech Inc. (AIM) has delivered -6.0% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1953 of 1993 stocks overall and #255 of 264 in the Health Care sector by Steady Score.
Industry
Biological Products
Steady Score
26.57
Overall Rank
#1953 / 1993
Sector Rank
#255 / 264
Revenue CAGR
-6.0%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio